Clinical Trial

Treatment of Neonatal Abstinence Syndrome With Clonidine Versus Morphine as Primary Therapy

Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The purpose of this study is to show non-inferiority between two medications used for medical treatment of withdrawal seen in Neonatal Abstinence Syndrome (NAS), Clonidine and Morphine Sulfate (used in routine care) on length of treatment for NAS .
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2017-03-21; most recent amendment 2024-10-09.
Status change: Recruiting → Active, Not Recruiting 2024-10-09
Status change: Not Yet Recruiting → Recruiting 2018-03-14
Trial Details
NCT Number NCT03092011
Lead Sponsor The Cooper Health System
Conditions Neonatal Abstinence Syndrome
Enrollment 69 participants
Start Date 2018-02-21
Primary Completion 2024-10-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2024-10-15